[250 Pages Report] The global copovidone market is estimated to register remarkable growth, expanding at a CAGR of around 9% to 10% during the forecast period 2022-2032. Increasing demand for non-toxic, and pharmaceutically inactive thickening and binding agents across diverse industries is expected to accelerate the sales of copovidone in the global market.
| Report Attribute | Details |
|---|---|
| Copovidone Market Projected Growth Rate (2022 to 2032) | 9% to 10% CAGR |
Copovidone is an analog of povidone which is commonly used as a fining agent, tablet binder, emulsifier, and a part of matrix materials in controlled-release formulations. This compound is increasingly used as an alternative to povidone, owing to its less hygroscopic, more elastic, and better plasticity attributes in comparison to povidone.
Copovidone is gaining huge traction as a film-forming agent and is being added to the coating solutions for enhancing its adhesion, elasticity, and hardness. It is finding a wide range of applications across various sectors such as industrial, ceramics, adhesives, battery, and others, on account of several benefits, it offers over other polymers. This is projected to accelerate the sales of copovidone in the global market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for copovidone is largely driven by favorable government regulations, policies, and standards. Numerous regulatory organization such as the U.S. Food & Drug Administration has approved using non-toxic and pharmaceutically inactive chemicals such as copovidone across industries such as food & beverage, pharmaceuticals, and personal care & cosmetics.
This, in addition to its excellent moisture barrier and binder properties, copovidone is finding usages as a soluble binder for gelatin capsules and as a dry binder for direct compression tableting across pharmaceutical industry. Hence, growing demand for tablets, pills, and capsules across the globe is projected to create lucrative growth opportunities in the copovidone market.
In the past couple of years, a rapid inclination towards the adoption of organic and natural cosmetics & personal care products is being witnessed, especially across developed countries such as the U.S., Germany, Japan, the U.K., and others. This is discouraging the industry players from making use of copovidone in their products, thereby, hampering the demand in the market.
Also, side effects associated with excessive consumption of copovidone such as stomach aches, nausea, diarrhea, and vomiting are further hindering the sales in the market.
Principal Consultant
South Asia is expected to account for a significant share in the global copovidone market from 2022 to 2032, reveals Future Market Insights.
Demand for therapeutic drugs such as tablets and pills is increasing at a rapid pace in South Asia, on account growing burden of numerous diseases and increasing adoption of personalized medicine. Hence, leading industry players are emphasizing on expanding their drugs production capacity to cater to this surging demand.
For instance, in 2021, Glenmark Life Science, an Indian manufacturer of drugs and therapeutics products announced its plan of investing around US$ 78.7 Mn for increasing its production capacity to more than double in the coming years. As copovidone is extensively used in capsules, tablets, and pills production, such developments are estimated to bolster the growth in the South Asia market.
A study by FMI states that North America is anticipated to register growth at a rapid CAGR in the global copovidone market during the forecast period 2022-2032.
Due to the increasing concerns regarding personal hygiene and growing consumer spending on enhancing the facial, body, and hair aesthetic, a substantial rise in sales of personal care & cosmetics products is being witnessed across North America.
As copovidone is extensively used as an emulsifier, binder, and thickening agent in the products such as toothpaste, moisturizers, shampoos, shaving lotions, and others, growing sales of these products are projected to augment the demand in the North America market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the leading players in the copovidone market profiled by FMI are Nanhang Industrial, Merck KGaA, Boai NKY Pharmaceuticals Ltd., BASF SE, Huangshan Bonsun Pharmaceuticals Co., Ltd., Ashland, Hangzhou Motto Science & Technology Co. Ltd., Shanghai Yuking Water Soluble Material Tech Co. Ltd., and others.
The market for copovidone is highly competitive, attributed to increasing research and development activities for launching novel products and adoption of production capacity expansion strategies by key companies.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9% to 10% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the sales of copovidone in the market is expected to rise at 9% to 10% value CAGR by 2032
The global copovidone market is expected to be dominated by the pharmaceutical industry over forecast period 2022-2032.
Nanhang Industrial, Merck KGaA, Boai NKY Pharmaceuticals Ltd., BASF SE, Huangshan Bonsun Pharmaceuticals Co., Ltd., Ashland, Hangzhou Motto Science & Technology Co. Ltd., Shanghai Yuking Water Soluble Material Tech Co. Ltd., others are some of the leading players in the prominent copovidone market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Copovidone Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Grade Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Grade Type , 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Grade Type , 2022-2032
5.3.1. Food Grade
5.3.2. Pharmaceutical Grade
5.3.3. Cosmetic Grade
5.4. Y-o-Y Growth Trend Analysis By Grade Type , 2017-2021
5.5. Absolute $ Opportunity Analysis By Grade Type , 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Form, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Form, 2022-2032
6.3.1. Liquid
6.3.2. Powder
6.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021
6.5. Absolute $ Opportunity Analysis By Form, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Functionality
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Functionality, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Functionality, 2022-2032
7.3.1. Granulating Agent
7.3.2. Retarding Agent
7.3.3. Film-forming Agent
7.3.4. Lubricant
7.3.5. Thickening Agent
7.3.6. Dispersant
7.3.7. Binding Agent
7.3.8. Emulsifying Agent
7.3.9. Fining Agent
7.3.10. Blocking Agent
7.3.11. Other Functionalities
7.4. Y-o-Y Growth Trend Analysis By Functionality, 2017-2021
7.5. Absolute $ Opportunity Analysis By Functionality, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Grade Type
9.2.3. By Form
9.2.4. By Functionality
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Grade Type
9.3.3. By Form
9.3.4. By Functionality
9.4. Key Takeaways
10. Latin America Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Mexico
10.2.1.2. Brazil
10.2.1.3. Rest of Latin America
10.2.2. By Grade Type
10.2.3. By Form
10.2.4. By Functionality
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Grade Type
10.3.3. By Form
10.3.4. By Functionality
10.4. Key Takeaways
11. Europe Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Grade Type
11.2.3. By Form
11.2.4. By Functionality
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Grade Type
11.3.3. By Form
11.3.4. By Functionality
11.4. Key Takeaways
12. East Asia Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Grade Type
12.2.3. By Form
12.2.4. By Functionality
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Grade Type
12.3.3. By Form
12.3.4. By Functionality
12.4. Key Takeaways
13. South Asia & Pacific Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. ASEAN
13.2.1.3. Australia and New Zealand
13.2.1.4. Rest of South Asia & Pacific
13.2.2. By Grade Type
13.2.3. By Form
13.2.4. By Functionality
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Grade Type
13.3.3. By Form
13.3.4. By Functionality
13.4. Key Takeaways
14. MEA Copovidone Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. Turkey
14.2.1.3. South Africa
14.2.1.4. Rest of MEA
14.2.2. By Grade Type
14.2.3. By Form
14.2.4. By Functionality
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Grade Type
14.3.3. By Form
14.3.4. By Functionality
14.4. Key Takeaways
15. Key Countries Copovidone Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Grade Type
15.1.2.2. By Form
15.1.2.3. By Functionality
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Grade Type
15.2.2.2. By Form
15.2.2.3. By Functionality
15.3. Mexico
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Grade Type
15.3.2.2. By Form
15.3.2.3. By Functionality
15.4. Brazil
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Grade Type
15.4.2.2. By Form
15.4.2.3. By Functionality
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Grade Type
15.5.2.2. By Form
15.5.2.3. By Functionality
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Grade Type
15.6.2.2. By Form
15.6.2.3. By Functionality
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Grade Type
15.7.2.2. By Form
15.7.2.3. By Functionality
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Grade Type
15.8.2.2. By Form
15.8.2.3. By Functionality
15.9. Spain
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Grade Type
15.9.2.2. By Form
15.9.2.3. By Functionality
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Grade Type
15.10.2.2. By Form
15.10.2.3. By Functionality
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Grade Type
15.11.2.2. By Form
15.11.2.3. By Functionality
15.12. China
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Grade Type
15.12.2.2. By Form
15.12.2.3. By Functionality
15.13. Japan
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Grade Type
15.13.2.2. By Form
15.13.2.3. By Functionality
15.14. South Korea
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Grade Type
15.14.2.2. By Form
15.14.2.3. By Functionality
15.15. India
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Grade Type
15.15.2.2. By Form
15.15.2.3. By Functionality
15.16. ASEAN
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Grade Type
15.16.2.2. By Form
15.16.2.3. By Functionality
15.17. Australia and New Zealand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Grade Type
15.17.2.2. By Form
15.17.2.3. By Functionality
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Grade Type
15.18.2.2. By Form
15.18.2.3. By Functionality
15.19. Turkey
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Grade Type
15.19.2.2. By Form
15.19.2.3. By Functionality
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Grade Type
15.20.2.2. By Form
15.20.2.3. By Functionality
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Grade Type
16.3.3. By Form
16.3.4. By Functionality
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Jianhua Group
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Merck KGaA
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Boai NKY Pharmaceuticals Ltd.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. BASF SE
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Ashland, Hangzhou Motto Science & Technology Co. Ltd.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Shanghai Yuking Water Soluble Material Tech Co. Ltd.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Food and Beverage Insights
View Reports
Copovidone Market
